Web icon Corona Update

COVID-19 Secure measures at H.E.L

Independent assessment of COVID security practices at H.E.L Group Headquarters   H.E.L Group continues to review and improve COVID security measures…

Find out more

H.E.L Group validates battery testi…

Testing protocols and equipment fully adheres to new compulsory standards for electric vehicle (EV) and lithium-ion battery safety Supports HEL’s commitment…

Find out more

H.E.L Group introduces labCONSOL la…

Next-generation software optimizes user experience and increases lab efficiency Customers supported with a pipeline of future system developments and automatic updates…

Find out more
Web icon Corona Update

Updated COVID-19 measures

1 June 2020   H.E.L Group continues to respond to the fast-changing situation that the Covid-19 pandemic presents. Our primary concern…

Find out more
Mert Sahin_3

Mert Sahin joins H.E.L Group as Gen…

GE Healthcare Commercial Executive brings a breadth of experience in scientific instrumentation and global markets to drive North American presence Borehamwood,…

Find out more
H.E.L Group appoints Kevin O’Donovan as Chair Appointment brings significant Board and commercial experience to deliver sustainable company growth Borehamwood, UK, 07 April 2020: H.E.L Group (H.E.L), a global developer and manufacturer of innovative laboratory tools for process optimization, safety and scale-up, today announced the appointment of Kevin O’Donovan as Chair of the H.E.L Board of Directors. Kevin takes over from interim Chair, Jon Andrew, and will guide the Company to deliver sustainable growth while continuing to help customers solve complex scientific challenges. Kevin is a Business Angel and has built up a portfolio of investments in the life sciences over the last 20 years, sitting on a number of Boards as Chair or Non-Executive Director. Several of these companies have been successfully sold, with listings on Ofex and AIM. Previously, Kevin founded the molecular biology instrumentation company, Hybaid, and directed its growth from concept to trade sale for £12 million. Here his expertise lay in export, and he successfully implemented a global network of 40 companies. Kevin has an MBA which he obtained from the UK’s Kingston Business School. The announcement of the new Chair follows a number of recent leadership team appointments and builds on the Company’s strong growth initiatives and focus on strengthening production and service support.

H.E.L Group appoints Kevin O’Dono…

Appointment brings significant Board and commercial experience to deliver sustainable company growth Borehamwood, UK, 07 April 2020: H.E.L Group (H.E.L), a…

Find out more
H.E.L Group - Measures taken in response to COVID-19-

Measures taken in response to COVID…

Like other businesses, H.E.L Group is responding to the fast-changing situation that COVID-19 presents to us. Our primary concern is for…

Find out more
H.E.L Group focuses on growth in Ch… Company bolsters presence in China with appointment of Qing (Steven) Chen as General Manager

H.E.L Group focuses on growth in Ch…

Company bolsters presence in China with appointment of Qing (Steven) Chen as General Manager and the establishment of a WFOE Borehamwood,…

Find out more
New H.E.L website

New website and new look for H.E.L

A new web experience With over 30 years’ experience, we understand that progress doesn’t happen without change, so we have updated…

Find out more
H.E.L Group focuses on growth in Ch… Company bolsters presence in China with appointment of Qing (Steven) Chen as General Manager

H.E.L Group Bolsters Production and…

Company appoints Global Quality Manager, Production Manager and Global Service Manager to its senior team Borehamwood, UK, 24th January 2020: H.E.L…

Find out more
mic_image_small_logo

Listen To Our Monthly Modern Chemis…

Have you ever wondered how modern science really underpins the way we live our lives today? Turns out that our CMO’s Paul…

Find out more
With over 20 years's experience in R&D and commercial roles at life science organizations, Paul Orange joins H.E.L. Group from GE Healthcare Life Sciences, where he led regional marketing teams around the world and drove a major e-commerce project for the multinational company. Paul has a Ph.D. in Neuroscience from the University of Sheffield, and has performed research at Manchester University, Amersham Pharmacia Biotech and NextGen Sciences. He has also worked in sales, marketing and business development roles at PerkinElmer. Paul Sturgeon started his career as a chartered accountant with Price Waterhouse, and since then has held CFO positions at organizations ranging from pre-revenue start-ups to established, multinational private equity-backed businesses. At H.E.L. Group, Paul will focus on enhancing operational efficiency, including leading the company-wide implementation of an enterprise resource planning (ERP) system.

H.E.L. Group strengthens senior man…

Borehamwood, UK, 26 November 2019: H.E.L. Group, a global manufacturer of innovative laboratory tools for process optimization, safety and scale-up, today announced the…

Find out more
H.E.L. Group appoints new CEO and s… Louise Madden joins as CEO to drive Company’s growth strategy Investment by Connection Capital supports H.E.L. Group

H.E.L. Group appoints new CEO and s…

Louise Madden joins as CEO to drive Company’s  growth strategy Investment by Connection Capital supports H.E.L. Group in servicing global demand…

Find out more

HEL Wins BIV Awards With University…

Most fermentation studies are carried out under ambient pressure. Although pressurized fermentation has been widely applied in the brewing industry to…

Find out more